Having trouble viewing this email? View in your browser.
ESCMID Logo

21 August 2018
WEEKLY NEWS

Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,

ESCMID Executive Office.

 

EUCAST pleas for standardization of antimicrobial codes for disk susceptibility testing

The increasing numbers of international manufacturers of disks for disk diffusion susceptibility testing has resulted in an increasing number of conflicting three-letter codes on disks. The same three-letter codes being used by different manufacturers for different antimicrobial agents. EUCAST believes that this represents an important patient safety issue because the laboratory may use the wrong disk and misreport the results to the treating clinicians. EUCAST has devised a mechanism for generating three-letter codes that would not result in conflicting codes, and asks that manufacturers and regulators alike consider adopting such a system.

› Read more
 

CMI highlight: No change in antibody responses to vaccination after probiotics administration in children

The use of probiotics has been suggested to improve vaccine responses. It is seen that the intestinal microbiota plays an important role in health and disease and in this regard, probiotics may facilitate stimulation of the host immune system. Furthermore, bacterial dysbiosis can induce systemic inflammation and lower the vaccine responses. The authors examined the effect of a combination of probiotics on the antibody response to pneumococcal and pertussis vaccination in Danish healthy children, aged 8-14 months, at the time of starting day care. The probiotic intervention did not affect the antibody response against S. pneumoniae and B. pertussis toxin in healthy Danish children. This may reflect how efficient the vaccines are and suggests that only immunocompromised individuals and elderly may benefit from probiotics to strengthen the outcome of vaccination. In contrast to the acellular vaccines used here, another outcome may be obtained by vaccines based on whole microorganisms.

› Read more
 

Call for ESCMID Excellence, Young Investigator and TAE Awards

Nominations are now being accepted until 11 October 2018 at 12:00 noon CET for the Award for Excellence in recognition of an outstanding lifetime contribution to science, education or professional affairs in the field of infection as well as for the Young Investigator Award, which rewards outstanding research and stimulates further studies at the highest scientific level. The TAE Award for Training Achievements, with the same nomination deadline, recognizes and rewards outstanding trainees in clinical microbiology and infectious diseases.

› Read more
 

ESCMID remembers colleague and friend Prof. Dr. med. Georg Matthias Peters

We at ESCMID were greatly saddened to learn that Georg Peters, Professor and director of the Institute of Medical Microbiology at the University Hospital Münster in Germany, suddenly passed away due to a mountain accident on 8th of August 2018. Prof. Peters has left us at age of 67, a few weeks before retiring from his professional activity.

Prof. Peters was an eminent clinical microbiologist and a worldwide known and highly regarded expert in the Staphylococcus community. He was an ESCMID member and an active contributor of the ESCMID Study Group for Staphylococci and Staphylococcal Diseases. He started his career at the University of Cologne, where in 1986 he was appointed as Professor after a stay at the University of Minnesota. Since 1992, he has been Director of the Institute of Medical Microbiology of the University Hospital in Münster.

Georg Peters had a very sharp mind and was an excellent scientist and clinical microbiologist, always focusing on the patient. He initiated in a large number of national and international research consortia and was active in scientific and ministerial committees and boards. He always had a friendly and open-minded attitude towards colleagues, trainees, students and whoever approached him to ask for his advice. Clinical Microbiology and Infectious Disease lost an important personality.

We send our sincerest condolences to his family.

› Read more
 

International Conference on Migration Health (ICMH) – ESCMID Grants

ESCMID is offering attendance grants to the ICMH, to be held in Rome, Italy from 1 – 3 September. ESCMID members are eligible to apply for these grants, with preference for young scientists and students. Please send a 100 word motivational letter, along with student identification (if applicable) to info@escmid.org.

› Read more
ESCMID Executive Office
P.O. Box 214
4010 Basel
Switzerland
Phone +41 61 5080 173
info@escmid.org
www.escmid.org
Follow ESCMID
Visit us on LinkedIn Visit us on YouTube
 
The ESCMID Newsletter is issued on behalf of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) by the ESCMID Executive Office. It contains announcements of ESCMID-related matters and other information of interest to professionals in the infection field.

Tip: To ensure that you receive the ESCMID newsletter in your inbox, add newsletter@escmid.org to your email program’s address book.

You have received this email as a contact of ESCMID or one of its affiliated societies. You can unsubscribe or change your newsletter subscriptions here.